PRIMERICA, INC. PRI

Zacks Investment Research 13 nov

Voya Financial (VOYA) has gained 44.5% over the past year, driven by strong Retirement business momentum, growing fee-based revenues, and improved Employee Benefits profitability. The company generated $225 million in excess capital in Q3 and expects over $800 million in 2026. However, competitive pressures and recent outflows of $5 billion in Investment Management assets pose risks. The stock is rated a Hold with a 4.7% upside potential.

Zacks Investment Research 11 nov

Zacks Premium offers Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the best performance potential. The article highlights Primerica (PRI) as a stock to watch, noting its #3 Hold rank with a B VGM Score and A Momentum Score, supported by recent upward earnings estimate revisions.

Zacks Investment Research 4 nov

Primerica reported Q3 2026 revenue of $901.82 million, up 7.5% year-over-year and slightly beating consensus estimates by 0.1%. EPS of $6.77 exceeded expectations by 5.95%. However, several key operational metrics fell short of analyst estimates, including average client asset values, life insurance policies issued, and sales force size. The company received a Zacks Rank #3 (Hold) rating.

Zacks Investment Research 2 nov

Oscar Health is expected to report Q3 2026 revenues of $4.7 billion (up 58.1% YoY) but with a loss of 11 cents per share. Strong ACA enrollment and premium increases should drive top-line growth, but the absence of Q2's $164 million reserve benefit and elevated outpatient utilization may pressure profits. The stock has a Zacks Rank #1 but an Earnings ESP of 0.00%, suggesting limited upside surprise potential.

Zacks Investment Research 27 oct

CNO Financial is set to report Q3 2026 earnings on October 29 with projected EPS of $1.09 (up 13.5%) but revenues expected to fall 16.7% to $993M. While the company has beaten earnings estimates for four consecutive quarters, its 0.00% Earnings ESP suggests an uncertain outlook for the upcoming quarter. Growth in health, Medicare Supplement, annuity, and Worksite sales may be offset by weaker Consumer life sales and higher technology modernization expenses.